Optiscan Biomedical

About

OptiScan BioMedical develops the OptiScanner, an automated bedside glucose monitoring system intended to help healthcare providers manage patients' glucose levels.

Summary

Optiscan Biomedical is a Healthcare company.

Similar Companies

MedlineIPO

Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...

Northfield, United States10001+Healthcare

Private Equity·$34.0B·Jan 2021

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare

Private Equity·$7.4B·Mar 2014

The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail

Private Equity·$7.0B·Jul 2017

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare

Growth Equity·$5.1B·Aug 2022

OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics

Extension Round·$5.1B·Dec 2025

Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare

Corporate Round·$4.5B·Jan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/optiscan-biomedical"><img src="https://indexed.vc/api/badge/company/optiscan-biomedical" alt="Optiscan Biomedical on Indexed.vc" width="260" height="76" /></a>